CTRI/2014/12/005274已完成3 期
A randomized double-masked, phase III study assessingranibizumab intravitreal injections versus sham control inpatients with visual impairment due to macular edema (ME)secondary to central retinal vein occlusion (CRVO)[Camellia] - Camellia
ovartis Healthcare Pvt Ltd0 个研究点目标入组 252 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 252
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with visual impairment secondary to central retinal vein occlusion (CRVO) with a BCVA between 24 and 73 letters in one eye and at least 35 letters in the other eye
排除标准
- •Pregnant or nursing women or women of child bearing potential without using an effective contraception
- •- Stroke or myocard infarction within 3 months prior to study
- •History of malignancy within the past 5 years
- •Uncontrolled hypertension
- •Active infection or inflammation in any eye
- •monocular patients
- •use of corticosteroids for at least 30 days in the last 6 months
- •treatment with anti-angiogenic drugs in any eye within last 3 months
- •laser photocoagulation within the last few months
- •Other protocol defined inclusion/exclusion criteria may apply
研究者
相似试验
进行中（未招募）
1 期
A study to test the efficacy and safety of riliprubart against the usual treatment of intravenous immunoglobulin (IVIg) in people with chronic inflammatory demyelinating polyneuropathy (CIDP)MedDRA version: 20.0Level: LLTClassification code: 10077384Term: Chronic inflammatory demyelinating polyneuropathy Class: 10029205Chronic Inflammatory Demyelinating PolyneuropathyCTIS2023-508338-33-00Sanofi-Aventis Recherche & Developpement229
已完成
3 期
A phase 3, randomized, double-blind study to evaluate the safety and efficacy of GS-9350-boosted Atazanavir versus Ritonavir-boosted Atazanavir each administered with Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 infected, antiretroviral treatment-naive adults.NL-OMON38379Gilead Sciences8
已完成
3 期
A phase 3, randomized, double-blind study to evaluate the safety and efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 versus Ritonavir-Boosted Atazanavir plus Emitricitabine/Tenofovir Disoproxil Fumarate in HIV-1 infected, antiretroviral treatment-naive adults.Human Immunodeficiency Virus (HIV-1) Infections10047438NL-OMON39337Gilead Sciences8
招募中
3 期
Comparative trial to evaluate the efficacy and safety of antibody treatment in patients with early breast cancerRBR-37f338Associação Hospital de Caridade Ijuí
进行中（未招募）
1 期
This trial is designed to determine what effects the human body has on the investigational medicine, ABP 710, and what effects the body has on the investigational medicine after you have been given it, and if this is comparable to what is seen for the licensed medicine, infliximab, in patients with moderate or severe rheumatoid arthritis (RA). This study will assess if the investigational medicine is safe and effective in treating moderate or severe RA compared to the licensed medicine.Rheumatoid arthritisEUCTR2014-004704-29-HUAmgen Inc.550